Qiara Pregnancy & Breastfeeding

A$79.00

Reduces symptoms and occurrence of mild mastitis.

Supports health during pregnancy and breastfeeding.

Quantity:
Get it here

Reduces symptoms and occurrence of mild mastitis.

Supports health during pregnancy and breastfeeding.

Reduces symptoms and occurrence of mild mastitis.

Supports health during pregnancy and breastfeeding.

Qiara Pregnancy & Breastfeeding contains a probiotic strain, Lactobacillus fermentum CECT 5716 isolated from breastmilk, formulated for mums like you.

Qiara can:

  • Reduce and relieve symptoms of mild mastitis[1][2]

  • Reduce the occurrence of mild mastitis

  • Help restore good gut and breast milk flora during and after antibiotic use, important for C-section or GBS positive mums and their babies[3]

  • Improve healthy digestive system function, before, during and even after pregnancy

  • Help restore the balance of good bacteria in breast milk that may have been reduced by antibiotics or other external factors[4]

  • Maintain and support gastrointestinal system health

  • Help improve good bacteria growth

Who Should Take Qiara Pregnancy & Breastfeeding Probiotics?

  • Any woman who is pregnant or trying to become pregnant

  • Any woman wanting to support general good health, gastrointestinal health and microbiome support during the entire pregnancy or at least in the last trimester

  • Any woman who is breastfeeding. Qiara is a probiotic strain that was originally derived from healthy breast milk flora (not from bowel flora). It transfers into breast milk which in turn may improve the infant's gut health

  • Both mum and baby benefit from Qiara Pregnancy and Breastfeeding - there is no need to give a separate probiotic to the baby if mum is taking Qiara

  • Any woman experiencing breast pain or symptoms of mild mastitis, Qiara may assist in reducing the symptoms and occurrence of mild mastitis

Seek medical advice if mastitis symptoms persist longer for longer 12 hours, or if your symptoms worsen.

What makes Qiara Probiotics Different?

Isolated from breastmilk

Lactobacillus fermentum CECT 5716 is a probiotic isolated from breast milk which:

  • Has a history of safe prolonged intake by newborns and infants.

  • Is uniquely adapted to reside both in the human digestive tract and in human breast milk and to interact with the human baby.

  • Has been clinically shown to pass into breast milk when taken orally by the mother.

It is safe for both mother and baby and may play a critical role in preventing local infection in breast tissue and establishing a healthy microbiome in the infant.

Single strain vs multi strain probiotic

It is important to select the right probiotic strain researched for and suited to your needs.

Many probiotic companies provide broad spectrum probiotics containing multiple strains in a single dose. However, clinical trials for probiotics are usually conducted with a single strain rather than with multiple strains, and it is unclear how multiple strains in a single dose may interact with or inhibit each other.

Qiara Pregnancy & Breastfeeding contains 3 billion microorganisms of Lactobacillus Fermentum CECT 5716, the same dosage of exactly the same single strain used in clinical trials.

Qiara Pregnancy and Breastfeeding AUSTL 269433:

  • Contains no added dairy, yeast, eggs, gluten, nuts, soy or salt.

  • No artificial colours, preservatives or sweeteners.

  • Contains no animal products.

  • Is suitable for Vegetarians and Vegans.

  • For further information, seek the advice of your healthcare professional.

References

  1. Hurtado J, et al (2017) Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial.  Breastfeeding Medicine May 2017. Vol 12 Issue 4.

  2. Arroyo R, Martín V, Maldonado A, Jiménez E, Fernández L, Rodríguez JM (2010) Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis. 2010 Jun 15;50(12):1551-8. doi: 10.1086/652763

  3. Soto A, Martín V, Jiménez E, Mader I, Rodríguez JM, Fernández L. Lactobacilli and Bifidobacteria in human breast milk: influence of antibiotherapy and other host and clinical factors. J Pediatr Gastroenterol Nutr. 2014;59:78–88.

  4. Maldonado-Lobón JA, et al. (2015) Lactobacillus fermentum CECT 5716 Reduces Staphylococcus Load in the Breastmilk of Lactating Mothers Suffering Breast Pain: A Randomized Controlled Trial. Breastfeeding Medicine 10(9), pp. 425-432. doi:10.1089/bfm.2015.0070

For further research and resources, https://www.qiara.com.au